Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/21/21
End: 10/07/21
Due: 10/07/22
Phase: N/A
Priority: Normal
Start: 12/21/21
End: 11/29/23
Due: 11/29/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations | NCT04969965 | EQRx, Inc. | user2@example.com | None | 2021-06-21 | 2021-10-07 | 2022-10-07 | - | - | 2025-07-14 |
| A Study of Lerociclib in Participants With Advanced Breast Cancer | NCT05085002 | EQRx, Inc. | user2@example.com | None | 2021-12-21 | 2023-11-29 | 2024-11-29 | - | - | 2025-07-14 |